Close
Novotech
Jabsco PureFlo 21 Single Use

Turkish Cargo continued its steady growth in 2019

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Structural Pricing Pressure is Reshaping Pharma in 2026

In 2026, global pricing pressure in the pharmaceutical sector has shifted from a temporary, cyclical issue to a structural constraint. Explore how U.S. reforms, European reference pricing, and biosimilar competition are forcing companies to embed pricing risk into core strategy.

Merck Targets $70B Revenue in 2026 with Cidara Deal

Merck’s roughly $9.2 billion acquisition of Cidara Therapeutics and its $70 billion revenue ambition mark a strategic pivot toward respiratory vaccines and antivirals. Explore how this deal reshapes Merck’s portfolio and signals a broader industry shift toward targeted M&A to offset patent cliffs.

U.S. Drug Pricing Reset Becomes Real in 2026

In 2026, U.S. drug pricing finally moved from policy debate to P&L impact. The first set of Medicare “maximum fair prices” and Most‑Favoured‑Nation–style reference pricing are reshaping pharma margins and launch strategies.
- Advertisement -

According to the international air cargo information provider WACD’s December data (cumulative), the global air cargo brand Turkish Cargo, which serves 127 countries of the world, grew significantly by achieving a tonnage increase of 7.1 percent in a sector wherein the global air cargo market shrank by -4.4 percent.

According to WACD data; Turkish Cargo, which has the largest growth rate among the top 10 airlines, rose to 7th place in the international air cargo industry and increased our global market share to 4.1 percent.

Turkish Cargo keeps growing in Far East and America markets

On the basis of the tonnage sold, the successful air cargo brand has grown by 17.1 percent in North and South America, 14.1 percent in the Far East Region, 9.7 percent in South Western Europe, 4.7 percent in the Middle East and South Asia, and 7.1 percent in Africa, thus achieving positive results in all regions wherein it provides air cargo service, and kept growing steadily in these regions.

In addition to the Turkish Airlines’ cargo carrying capacity, Turkish Cargo performs direct cargo flights to 88 destinations with its cargo aircraft fleet and has achieved a sustainable growth through its current infrastructure and newly made investments. Turkish Cargo continues to increase its capacity through successful operations in over 300 destinations covered by its current flight network.

Serving 321 destinations in 127 countries, the successful air cargo brand reaches new heights by combining its broad range of services and operational capabilities with Turkey’s unique geographical advantages.

To view the flight schedules and details please visit www.turkishcargo.com.tr, or contact with the call center at +90 850 333 0 777.

About Turkish Cargo:

In addition to the flight network of Turkish Airlines, which flies to more destinations than any other airline with 127 countries in its flight network, Turkish Cargo provides more than 300 destinations air cargo services, 88 of them direct cargo flight destinations. Turkish Cargo serves with 24 cargo freighters as well as the fleet of 358 planes of Turkish Airlines from Istanbul hub, which has strategic importance linking the continents. Our goal, as the fastest growing and developing air cargo brand in the world, is to be one of the top 5 air cargo carriers in 2023. For more; www.turkishcargo.com.tr

 

 

Latest stories

Related stories

Structural Pricing Pressure is Reshaping Pharma in 2026

In 2026, global pricing pressure in the pharmaceutical sector has shifted from a temporary, cyclical issue to a structural constraint. Explore how U.S. reforms, European reference pricing, and biosimilar competition are forcing companies to embed pricing risk into core strategy.

Merck Targets $70B Revenue in 2026 with Cidara Deal

Merck’s roughly $9.2 billion acquisition of Cidara Therapeutics and its $70 billion revenue ambition mark a strategic pivot toward respiratory vaccines and antivirals. Explore how this deal reshapes Merck’s portfolio and signals a broader industry shift toward targeted M&A to offset patent cliffs.

U.S. Drug Pricing Reset Becomes Real in 2026

In 2026, U.S. drug pricing finally moved from policy debate to P&L impact. The first set of Medicare “maximum fair prices” and Most‑Favoured‑Nation–style reference pricing are reshaping pharma margins and launch strategies.

White House-Big Pharma Tariff and Pricing Deals in 2026

In early 2026, the White House struck a series of tariff and pricing deals with major pharma firms, linking lower prices for GLP‑1 and other drugs to tariff relief and new distribution channels. Explore how these arrangements are reshaping U.S. pharma pricing, access and global spillovers.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »